Lataa...
Outcomes of 596 Advanced Gastric Cancer Patients with Different Numbers of Chemotherapy Lines: The More Chemotherapy Lines, the Better Survival
OBJECTIVE: Many large-sample prospective randomized clinical trials investigating advanced gastric cancer (AGC) have confirmed the survival advantages of first-line, second-line, or third-line chemotherapy compared with their respective control groups. However, due to the ethical concerns of prospec...
Tallennettuna:
| Julkaisussa: | Cancer Manag Res |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7602914/ https://ncbi.nlm.nih.gov/pubmed/33149671 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S275990 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|